96 related articles for article (PubMed ID: 28339090)
1. Inhibition of farnesyl pyrophosphate synthase attenuates high glucose‑induced vascular smooth muscle cells proliferation.
Chen GP; Zhang XQ; Wu T; Han J; Ye D
Mol Med Rep; 2017 May; 15(5):3153-3160. PubMed ID: 28339090
[TBL] [Abstract][Full Text] [Related]
2. Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.
Chen GP; Zhang XQ; Wu T; Li L; Han J; Du CQ
J Diabetes Res; 2015; 2015():379287. PubMed ID: 25918730
[TBL] [Abstract][Full Text] [Related]
3. Calcium sensing receptor regulating smooth muscle cells proliferation through initiating cystathionine-gamma-lyase/hydrogen sulfide pathway in diabetic rat.
Zhong X; Wang Y; Wu J; Sun A; Yang F; Zheng D; Li T; Dong S; Zhao Y; Yang G; Xu C; Sun D; Lu F; Zhang W
Cell Physiol Biochem; 2015; 35(4):1582-98. PubMed ID: 25824457
[TBL] [Abstract][Full Text] [Related]
4. Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.
Yang J; Chen YN; Xu ZX; Mou Y; Zheng LR
Cell Physiol Biochem; 2016; 39(1):229-41. PubMed ID: 27336844
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
[TBL] [Abstract][Full Text] [Related]
6. Alpha-lipoic acid regulates the autophagy of vascular smooth muscle cells in diabetes by elevating hydrogen sulfide level.
Qiu X; Liu K; Xiao L; Jin S; Dong J; Teng X; Guo Q; Chen Y; Wu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3723-3738. PubMed ID: 30251691
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling.
Zhao CZ; Zhao XM; Yang J; Mou Y; Chen B; Wu HD; Dai DP; Ding J; Hu SJ
Sci Rep; 2016 Dec; 6():39186. PubMed ID: 28008986
[TBL] [Abstract][Full Text] [Related]
10. DR1 activation promotes vascular smooth muscle cell apoptosis via up-regulation of CSE/H
Wen X; Xi Y; Zhang Y; Jiao L; Shi S; Bai S; Sun F; Chang G; Wu R; Hao J; Li H
FASEB J; 2022 Jan; 36(1):e22070. PubMed ID: 34859931
[TBL] [Abstract][Full Text] [Related]
11. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells.
Yang G; Wu L; Bryan S; Khaper N; Mani S; Wang R
Cardiovasc Res; 2010 Jun; 86(3):487-95. PubMed ID: 20051385
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.
Wang Y; Panasiuk A; Grainger DW
Mol Pharm; 2011 Aug; 8(4):1016-24. PubMed ID: 21186792
[TBL] [Abstract][Full Text] [Related]
13. Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.
Cheung SH; Kwok WK; To KF; Lau JY
PLoS One; 2014; 9(11):e113038. PubMed ID: 25397776
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.
Li L; Chen GP; Yang Y; Ye Y; Yao L; Hu SJ
Biochem Pharmacol; 2010 Feb; 79(3):399-406. PubMed ID: 19800872
[TBL] [Abstract][Full Text] [Related]
17. Geranylgeranyl Transferase-I Knockout Inhibits Oxidative Injury of Vascular Smooth Muscle Cells and Attenuates Diabetes-Accelerated Atherosclerosis.
Chen GP; Yang J; Qian GF; Xu WW; Zhang XQ
J Diabetes Res; 2020; 2020():7574245. PubMed ID: 32851097
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the cystathionine-gamma-lyase/hydrogen sulfide pathway in rat vascular smooth muscle cells by cobalt-60 gamma radiation.
Zhong GZ; Yang XC; Jia LP; Chen FR; Cui M
Chin Med J (Engl); 2009 Feb; 122(3):326-30. PubMed ID: 19236813
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
